| Product Code: ETC7536783 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India antiparasitic drugs market import shipments displayed robust growth with a CAGR of 10.7% from 2020 to 2024. The momentum further accelerated, showing a significant growth rate of 67.5% between 2023 and 2024. The market clearly expanded rapidly over the years, indicating a strong upward trend.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Antiparasitic Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Antiparasitic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Antiparasitic Drugs Market - Industry Life Cycle |
3.4 India Antiparasitic Drugs Market - Porter's Five Forces |
3.5 India Antiparasitic Drugs Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 India Antiparasitic Drugs Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 India Antiparasitic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of parasitic infections in India |
4.2.2 Growing awareness about the importance of antiparasitic drugs for public health |
4.2.3 Rising investments in healthcare infrastructure and research development in the pharmaceutical sector |
4.3 Market Restraints |
4.3.1 High competition from generic drug manufacturers leading to pricing pressures |
4.3.2 Limited access to healthcare services in rural areas hindering the reach of antiparasitic drugs |
4.3.3 Regulatory hurdles and approval processes affecting the market entry of new antiparasitic drugs |
5 India Antiparasitic Drugs Market Trends |
6 India Antiparasitic Drugs Market, By Types |
6.1 India Antiparasitic Drugs Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 India Antiparasitic Drugs Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 India Antiparasitic Drugs Market Revenues & Volume, By HIV, 2021- 2031F |
6.1.4 India Antiparasitic Drugs Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.1.5 India Antiparasitic Drugs Market Revenues & Volume, By Influenza, 2021- 2031F |
6.1.6 India Antiparasitic Drugs Market Revenues & Volume, By TB, 2021- 2031F |
6.1.7 India Antiparasitic Drugs Market Revenues & Volume, By Malaria, 2021- 2031F |
6.1.8 India Antiparasitic Drugs Market Revenues & Volume, By HPV, 2021- 2031F |
6.2 India Antiparasitic Drugs Market, By End Use |
6.2.1 Overview and Analysis |
6.2.2 India Antiparasitic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 India Antiparasitic Drugs Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 India Antiparasitic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 India Antiparasitic Drugs Market Import-Export Trade Statistics |
7.1 India Antiparasitic Drugs Market Export to Major Countries |
7.2 India Antiparasitic Drugs Market Imports from Major Countries |
8 India Antiparasitic Drugs Market Key Performance Indicators |
8.1 Number of healthcare facilities offering antiparasitic treatments |
8.2 Percentage of the population covered under government healthcare schemes for parasitic infections |
8.3 Research and development expenditure on innovative antiparasitic drug formulations |
9 India Antiparasitic Drugs Market - Opportunity Assessment |
9.1 India Antiparasitic Drugs Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 India Antiparasitic Drugs Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 India Antiparasitic Drugs Market - Competitive Landscape |
10.1 India Antiparasitic Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Antiparasitic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here